EUVIMEDEUVIMED entdecken
Crossref

From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease

Monica Esteban-Garcia, Iseult M. Browne, Alicia F. C. Okines

Oncology Research · 2026 · 1-10

DOI: 10.32604/or.2026.090148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Monica Esteban-Garcia und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Esteban-Garcia, M., Browne, I. M., & Okines, A. F. C. (2026). From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.090148

Vancouver

Esteban-Garcia M, Browne IM, Okines AFC. From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.090148

BibTeX
@article{EstebanGarcia2026,
  author = {Esteban-Garcia, Monica and Browne, Iseult M. and Okines, Alicia F. C.},
  title = {From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease},
  journal = {Oncology Research},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {1--10},
  doi = {10.32604/or.2026.090148}
}
Kostenlos starten →